pancreatic cancer

Showing NaN - NaN of 143

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Cancer Trial in New York (Biopsy, FOLFIRINOX, Ciprofloxacin)

Not yet recruiting
  • Pancreatic Cancer
  • Biopsy
  • +5 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 13, 2022

Pancreatic Cancer, Advanced Pancreatic Ductal Adenocarcinoma Trial in United States (Gemcitabine, Nab-paclitaxel, PEGPH20)

Active, not recruiting
  • Pancreatic Cancer
  • Advanced Pancreatic Ductal Adenocarcinoma
  • Hartford, Connecticut
  • +9 more
Jul 15, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

Active, not recruiting
  • Breast Cancer
  • +10 more
  • Los Angeles, California
  • +7 more
Jun 21, 2022

Pancreatic Cancer Trial in United States (Hypofractionated ablative IMRT (HFA-IMRT), capecitabine)

Active, not recruiting
  • Pancreatic Cancer
  • Basking Ridge, New Jersey
  • +7 more
May 4, 2022

Pancreatic Cancer, Tumors That Express CA19-9 Trial in United States (MVT-2163, MVT-5873)

Recruiting
  • Pancreatic Cancer
  • Tumors That Express CA19-9
  • Basking Ridge, New Jersey
  • +6 more
May 3, 2022

Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)

Completed
  • Colorectal Cancer (CRC)
  • +10 more
  • San Francisco, California
  • +16 more
Mar 30, 2022

Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

Completed
  • Advanced Solid Tumors
  • +6 more
  • Cabiralizumab
  • Nivolumab
  • Scottsdale, Arizona
  • +38 more
Jan 5, 2022

Pancreatic Cancer, Pancreatic Adenocarcinoma, Pancreas Ductal Adenocarcinoma Trial in United States (Nab-paclitaxel and

Active, not recruiting
  • Pancreatic Cancer
  • +2 more
  • Nab-paclitaxel and gemcitabine for R-PDAC Patients
  • Nab-paclitaxel and gemcitabine for BR-PDAC Patients
  • Scottsdale, Arizona
  • +3 more
Mar 8, 2022

Cancer of Pancreas, Cancer of the Pancreas, Tumors, Pancreatic Trial in Boston, New York (Talabostat Mesylate)

Withdrawn
  • Cancer of Pancreas
  • +4 more
  • Talabostat Mesylate
  • Boston, Massachusetts
  • +1 more
Feb 8, 2022

Advanced Solid Tumors, Solid Tumors, Ovarian Cancer Trial in Australia, United States (TALZENNA capsule, Talazoparib soft gel

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • TALZENNA capsule
  • Talazoparib soft gel capsule
  • Encinitas, California
  • +31 more
Feb 14, 2022

Pancreatic Cancer Trial in United States (Stereotactic Body Radiotherapy (SBRT))

Active, not recruiting
  • Pancreatic Cancer
  • Stereotactic Body Radiotherapy (SBRT)
  • Basking Ridge, New Jersey
  • +6 more
Feb 11, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Life Changes Experienced by Patients With Pancreatic Cancer

Active, not recruiting
  • Pancreatic Cancer
  • Measurement of Transitions in Cancer Scale (MOT-CA) Survey
  • Distress Thermometer Survey
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Feb 2, 2022

Kidney Cancer, Head Neck Cancer, Breast Cancer Trial in New York (177Lu-J591)

Completed
  • Kidney Cancer
  • +8 more
  • New York, New York
    Weill Cornell Medical College
Feb 1, 2022

Pancreatic Cancer Trial in United States (Atezolizumab, RO7198457, mFOLFIRINOX)

Active, not recruiting
  • Pancreatic Cancer
  • Basking Ridge, New Jersey
  • +6 more
Jan 12, 2022

Frequency of Methods of Local Invasion of Pancreatic

Active, not recruiting
  • Pancreatic Cancer
    • New York, New York
      Columbia University Irving Medical Center
    Jan 5, 2022

    Pancreatic Cancer Trial in United States (Whole liver irradiation (WLI), Gemcitabine and Cisplatin)

    Recruiting
    • Pancreatic Cancer
    • Whole liver irradiation (WLI)
    • Gemcitabine and Cisplatin
    • Basking Ridge, New Jersey
    • +6 more
    Dec 20, 2021

    Pancreatic Cancer Trial in Israel, United States (Stereotactic MRI-guided On-table Adaptive Radiation Therapy)

    Active, not recruiting
    • Pancreatic Cancer
    • Stereotactic MRI-guided On-table Adaptive Radiation Therapy
    • Los Angeles, California
    • +12 more
    Nov 18, 2021

    Tissue & Blood From Patients w/ Benign & Malignant Tumors of

    Active, not recruiting
    • Esophageal Cancer
    • +6 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Nov 12, 2021

      Interrogation of Exosome-mediated Intercellular Signaling in

      Recruiting
      • Pancreatic Cancer
      • Benign Pancreatic Disease
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Nov 11, 2021

        A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

        Recruiting
        • Pancreatic Cancer
        • +3 more
        • Blood Draw
        • +2 more
        • Middletown, New Jersey
        • +12 more
        Nov 10, 2021

        Pancreatic Cancer Trial in New York, Seattle (Nivolumab + Cabiralizumab, Stereotactic Body Radiotherapy (SBRT))

        Terminated
        • Pancreatic Cancer
        • Nivolumab + Cabiralizumab
        • Stereotactic Body Radiotherapy (SBRT)
        • New York, New York
        • +1 more
        Sep 22, 2021